## Abstract Recent studies have suggested that quantifying the serum HBsAg levels can predict the response to pegylated interferon. We aimed to determine the change in serum HBsAg levels during entecavir (ETV) treatment and the correlation with treatment response in chronic HBeAgβpositive and HBeAg
β¦ LIBER β¦
Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B
β Scribed by Okuhara, Sadahisa; Umemura, Takeji; Joshita, Satoru; Shibata, Soichiro; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Ota, Masao; Tanaka, Eiji
- Book ID
- 121741119
- Publisher
- John Wiley and Sons
- Year
- 2014
- Tongue
- English
- Weight
- 252 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1386-6346
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Correlation of serum hepatitis B surface
β
Myoung Hee Lee; Da Mi Lee; Soon Sun Kim; Jae Youn Cheong; Sung Won Cho
π
Article
π
2011
π
John Wiley and Sons
π
English
β 117 KB
π 2 views
484 HEPATITIS B CORE-RELATED ANTIGEN AND
β
Y. Seo; Y. Yano; A. Miki; M. Saito; T. Azuma
π
Article
π
2012
π
Elsevier Science
π
English
β 78 KB
Off-therapy durability of response to en
β
Jeng, Wen-Juei; Sheen, I-Shyan; Chen, Yi-Cheng; Hsu, Chao-Wei; Chien, Rong-Nan;
π
Article
π
2013
π
John Wiley and Sons
π
English
β 912 KB
Are alanine aminotransferase, hepatitis
β
Claudio Zavaglia; Luca Mondazzi; Giovanni Maggi; Gianmaria Lamoni; Franco Gelosa
π
Article
π
2008
π
John Wiley and Sons
π
English
β 507 KB
Association of on-treatment serum hepati
β
Soon Sun Kim; Dami Lee; Myoung Hee Lee; Jae Youn Cheong; Sung Won Cho
π
Article
π
2012
π
John Wiley and Sons
π
English
β 838 KB
Effect of corticosteroid therapy on leve
β
Maria H. Sjogren; Jay H. Hoofnagle; Jeanne G. Waggoner
π
Article
π
1987
π
John Wiley and Sons
π
English
β 405 KB
π 2 views
## Serum levels of antibody to hepatitis B core antigen and IgM antibody to hepatitis B core antigen were tested in 15 patients who participated in a randomized, placebo-controlled trial of a 28-day course of prednisolone therapy. During treatment, serum levels of antibody to hepatitis B core anti